BERNARDO NG: Open Payments
NPI 1598780736 · IMPERIAL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,318 in 91 payments from 18 companies in 2025. Trend: 2023 $1,600 · 2024 $1,619 · 2025 $5,318
Food & beverage: $2,786Consulting: $2,400Education: $132
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 6 | $2,478 |
| Otsuka America Pharmaceutical, Inc. | 16 | $503 |
| Teva Pharmaceuticals USA, Inc. | 7 | $414 |
| ABBVIE INC. | 18 | $413 |
| Neurocrine BioSciences, Inc. | 7 | $286 |
| Alkermes, Inc. | 8 | $268 |
| Eisai Inc. | 2 | $157 |
| Sage Therapeutics, LLC | 1 | $149 |
| Axsome Therapeutics, Inc. | 6 | $139 |
| Supernus Pharmaceuticals, Inc. | 5 | $115 |
Products named: ZURZUVAE, REXULTI, VRAYLAR, UZEDY, INGREZZA, LYBALVI, Leqembi, Auvelity.
Industry payments across CA — which companies pay providers there.
